Skip to main content
Clinical Trials/NCT00082485
NCT00082485
Completed
Phase 2

Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence

National Institute on Drug Abuse (NIDA)8 sites in 1 country160 target enrollmentJune 2004

Overview

Phase
Phase 2
Intervention
Placebo
Conditions
Cocaine-Related Disorders
Sponsor
National Institute on Drug Abuse (NIDA)
Enrollment
160
Locations
8
Primary Endpoint
Effects of medication on cocaine craving
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to assess the efficacy and safety of baclofen for the treatment of cocaine dependence.

Detailed Description

Double-blind, placebo-controlled, parallel design trial of baclofen for the treatment of cocaine dependence

Registry
clinicaltrials.gov
Start Date
June 2004
End Date
July 2006
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Subject must have DSM-IV diagnosis of cocaine dependence.
  • Subject must be seeking treatment for cocaine dependence.
  • Be be able to verbalize understanding of consent form, provide written consent and verbalize willingness to complete study procedures.

Exclusion Criteria

  • Please contact site for more information.

Arms & Interventions

2

Intervention: Placebo

1

Intervention: Baclofen

Outcomes

Primary Outcomes

Effects of medication on cocaine craving

Study Sites (8)

Loading locations...

Similar Trials